Articles

Congress highlights 2018

BJMO - , issue ,

D. De Maeseneer MD, F.X. Otte MD, S. Albisinni MD

ASCO GU represents one of the yearly highlights in the field of genitourinary cancer. During BMUC 2018 the key data presented at this meeting were summarized.

Read more

Congress highlights 2018

BJMO - volume 12, issue 10, march 2018

D. De Maeseneer MD, F.X. Otte MD, S. Albisinni MD

ASCO GU represents one of the yearly highlights in the field of genitourinary cancer. During BMUC 2018 the key data presented at this meeting were summarized.

Read more

3rd Belgian Multidisciplinary Meeting on Urological Cancers

BJMO - volume 10, issue 6, september 2016

T. Vermassen PhD, R. de Wit MD, PhD, R. van Velthoven MD, PhD, S. Albisinni MD, N. Martínez Chanzá MD, F. Aoun MD, MSc, E. Seront MD, PhD, S. Rottey MD, PhD

Summary

Due to the success of last year, a third national Belgian Multidisciplinary scientific meeting on Urological Cancers was held with the cooperation of medical oncologists (BSMO), urologists (BAU) and radiation oncologists (ABRO/BVRO). It was a great opportunity to build bridges between these three important specialisms involved in the treatment of urological cancers.
The steering committee of the meeting consisted of J.P. Machiels, G. Pelgrims, S. Rottey (members of BSMO), L. Hoekx, S. Joniau, T. Roumeguere (members of BAU), O. De Hertogh, G. De Meerleer and Y. Neybuch (members of ABRO-BVRO). The third meeting, held in La Hulpe, Brussels on March 5th, 2016 was a great success with more than 100 attendees of the different specialisms involved.
In this report of the meeting you can find a summary of the most important lectures given at the symposium.

(BELG J MED ONCOL 2016;10(6):232–235)

Read more

Cryotherapy and radiofrequency ablation for renal cell carcinoma

BJMO - volume 10, issue 3, may 2016

F. Aoun MD, MSc, S. Albisinni MD, R. van Velthoven MD, PhD

Summary

Thermal ablation is being increasingly used for the treatment of clinical stage T1a renal cell carcinoma. However, it is not uncommon to hear mixed messages regarding this issue. Hence, it is necessary for every urologist to understand the basics of thermal ablation and its clinical outcome based on the latest literature to help guide their patients through treatment options. Patient selection criteria are also analysed. Among thermal ablation techniques, cryotherapy and radiofrequency are the most commonly performed ablative procedures. The superiority of one technique over the other is difficult to demonstrate in the absence of a randomised controlled trial. Local recurrence seems more likely after radiofrequency ablation than after cryotherapy, with the latter achieving better local control. When compared to partial nephrectomy, higher local recurrence rates are described with the thermal ablation techniques. However, the small difference at five year follow-up and the better tolerability profile of thermal ablation procedures in elderly and/or comorbid patients explain the rationale for their use in selected cases. Follow-up is mandatory in these patients to diagnose recurrence or persistence of the disease, to monitor renal function and to detect complications. Of note, redo-techniques and surgical approach, though challenging, remain possible salvage procedures after primary failure.

(BELG J MED ONCOL 2016;10(3):85–91)

Read more